RankAlpha logo
Back to Rankings

FHTX

Foghorn TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
FHTX vs peer average
90/100
FHTX vs. peer average (A vs. C)
Grade spread
A 1 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CMPX is the first available peer comparator.

Similar-market-cap clinical-stage biotechnology candidate, but the packet provides no validated overlap in target biology, indication, development stage, or partnership economics; useful only as a broad event-risk reference.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCMPXCompass Therapeutics
FHTX
Foghorn Therapeutics
CMPX
Compass Therapeutics
Grade
A
C
Momentum
81
35
Value
41
41
Sentiment
97
66
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs CMPX

FHTX / CMPX
Grade Position
Above peers
FHTX vs. peer average (A vs. C)
90/100
Momentum
81
FHTX
Value
41
FHTX
Sentiment
97
FHTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FHTX
1
CMPX
CMPX
C
60/100
+2
2
FENC
FENC
D
40/100
+3
3
LXEO
LXEO
F
20/100
+4
4
UPB
Upstream Bio Inc Common
F
20/100
+4
5
TKNO
Alpha Teknova Inc Common
C
60/100
+2
CMPX is the first peer returned for this comparison set.